The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer.
Nakashoji A, Hayashida T, Yokoe T, Maeda H, Toyota T, Kikuchi M, Watanuki R, Nagayama A, Seki T, Takahashi M, Abe T, Kitagawa Y.
Nakashoji A, et al. Among authors: takahashi m.
Cancer Treat Rev. 2018 Jan;62:9-17. doi: 10.1016/j.ctrv.2017.10.009. Epub 2017 Oct 31.
Cancer Treat Rev. 2018.
PMID: 29127857
Review.